Novo Nordisk diabetes drug sales slow sharply
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Category : Search result: Novo Nordisk
Wegovy sales boost Novo Nordisk shares
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Wegovy weight-loss jab in high demand amid US obesity crisis
The US obesity epidemic has led to soaring demand for Wegovy, a weight-loss injection containing semaglutide. Experts warn of supply shortages as prescriptions surge.
Page 1 of 1